GSGuanling Song

Guanling Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guanling Song has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Li Li

    Shihezi Univ, Sch Med, Dept Prevent Med, Xinjiang Prod & Construct Corps,Key Lab Prevent &, Shihezi 832000, Xinjiang, Peoples R China

    7 shared publications
  • Yunhua Hu

    Department of Preventive Medicine, School of Medicine, Shihezi University, Shihezi, Xinjiang, China

    7 shared publications
  • Qianqian Wang

    Department of Preventive Medicine/ the Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, School of Medicine, Shihezi University, Shihezi 832000, Xinjiang, China; Shihezi City Center for Disease Control and Prevention, Eighth Division, Xinjiang Production and Construction Corps, Shihezi 832000, Xinjiang, China

    6 shared publications
  • Yunhua Hu

    Department of Preventive Medicine, School of Medicine Shihezi University Shihezi Xinjiang China

    6 shared publications
  • Hongmei Chang

    Department of Preventive Medicine/the key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, School of Medicine Shihezi University Shihezi Xinjiang China

    5 shared publications
  • Ruoyun Dong

    Department of Preventive Medicine/ the Key Laboratory for Prevention and Control of Emerging Infectious Diseases and Public Health Security, the Xinjiang Production and Construction Corps, School of Medicine, Shihezi University, Shihezi, China

    5 shared publications

Latest Publications

  • Association and Toxic Mechanism Between Foodborne OTA Exposure and Embryonic Development

    by Teng Yao, Xingyun Zhu, Jiaolong Ma, Guanling Song, Yunhua Hu, Yizhong Yan

    This study aimed to integrate bioinformatics and in vivo experiments to explore the embryonic developmental toxicity and specific mechanism of foodborne ochratoxin A (OTA), and to provide new discoveries and evidence for the prevention and control of foodborne contaminants. Bioinformatic analyses were performed to conduct Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of differentially expressed genes (DEGs) and oxidative stress–related DEGs (OSDEGs), and to screen hub genes through protein–protein interaction (PPI) networks; subsequently, ROC curve validation and molecular docking were carried out for the hub genes, followed by construction of a targeted miRNA network. On the other hand, different OTA exposure dose models in pregnant C57BL/6 mice were established to evaluate embryonic development, detect placental oxidative stress indicators, and measure protein expression levels of the PI3K/Akt/Nrf2/HO‐1 pathway. The results demonstrated that OSDEGs were mainly enriched in PI3K/Akt pathways. The hub genes exhibited AUC values above 0.75 and molecular docking binding energies ≤ −5 kcal/mol. Additionally, six miRNAs targeting hub genes were predicted. In the established OTA exposure models, high‐dose dams showed impaired weight gain, significantly reduced live fetus rates, and fetal malformations compared with controls. In exposure groups, placental glutathione levels decreased while malondialdehyde increased, accompanied by downregulated expression of Nrf2/HO‐1 and p‐PI3K/p‐Akt. In conclusion, OTA can suppress the phosphorylation level of PI3K/Akt, thereby affecting the protein expression of the Nrf2/HO‐1 signaling pathway, leading to inhibition of the body's antioxidant capacity and subsequently triggering oxidative stress, causing embryonic developmental toxicity.

  • Estimating the Global Burden and Health Risks Associated with Dietary and Cigarette-Related Cadmium Exposure

    by Jianjiang Shao, Guanling Song, Yunhua Hu, Qiang Niu, Yizhong Yan

    To quantitatively assess the global burden and health risks associated with dietary and cigarette-related cadmium (Cd) exposure, and to provide a scientific basis for developing public health policies for the prevention and control of global Cd exposure. This study combined the Cd concentration data in foods and cigarettes and their consumption data to assess the Cd exposure levels from these two sources. The toxicity kinetics (TK) model was used to convert dietary Cd exposure into urinary Cd (U-Cd) exposure to further evaluate the burden of cardiovascular disease (CVD) caused by dietary Cd exposure. The risk assessment model of the United States Environmental Protection Agency (USEPA) was adopted to evaluate the cancer and non-cancer risks caused by cigarette-related Cd exposure. The global average daily dietary Cd intake was 2.20 μg/kg bw/day. The daily Cd exposure to cigarettes was 0.0359 μg/kg bw/day. The proportions of the burden of CVD, stroke and coronary heart disease (CHD) explained by dietary Cd intake were 6.08%, 3.34% and 2.74%, respectively. The excess lifetime cancer risk (ELCR) due to cigarette-related Cd exposure was 0.0037, and the non-cancer hazard quotient (NCHQ) was 26.89. Cd exposure in diet and cigarettes significantly affects the global CVD burden and cancer risk. This study emphasizes the importance of reducing Cd exposure in the environment and formulating relevant policies to mitigate health risks, including strengthening Cd control in food and implementing effective and reasonable tobacco control policies.


  • Synergistic Effect of ROS and p38 MAPK in Apoptosis of TM4 Cells Induced by Titanium Dioxide Nanoparticles

    by Pengfei Li, Xiaojia Meng, Tianjiao Lu, Chenhao Sun, Guanling Song

    The adverse effects of titanium dioxide nanoparticles (TiO2 NPs) on the integrity of the blood–testis barrier (BTB) are widely recognized. However, the underlying mechanisms remain incompletely understood. The integrity of the BTB is imperative for the preservation of male reproductive health. TM4 cells, which are major component of the BTB, play a critical role in its integrity. The apoptosis of TM4 cells is closely associated with the disruption of the BTB. Therefore, we selected TM4 cells as experimental models to investigate the apoptosis induced by TiO2 NPs and the underlying mechanisms. Cell viability, excessive production of reactive oxygen species (ROS), activation of p38 mitogen‐activated protein kinase (MAPK) pathway, and apoptosis‐related protein expression levels were determined under various concentrations (50, 100, 150, and 200 μg/mL) of TiO2 NPs exposure. The results indicate that TiO2 NPs induced the overproduction of ROS and activated the p38 MAPK signaling pathway, which subsequently led to apoptosis. The ROS scavenger N‐acetylcysteine (NAC) was able to suppress the activation of p38 MAPK pathway induced by TiO2 NPs, while the p38 MAPK inhibitor SB203580 mitigated TiO2 NPs‐induced ROS overproduction and subsequent apoptosis, suggesting an interplay between ROS overproduction and p38 MAPK pathway activation. In summary, TiO2 NPs induced mitochondrial apoptosis via the ROS‐p38 MAPK axis. A positive feedback regulatory mechanism exists between the two processes, promoting apoptosis in TM4 cells through a synergistic effect.

  • The Role of CXCL13 in GC‐1 Cell Cycle Arrest Induced by Titanium Dioxide Nanoparticles Through JAK2/STAT3 Signaling Pathway

    by Yuzhu Lei, Ruoyun Dong, Chenhao Sun, Yunhua Hu, Yizhong Yan, Guanling Song, Yan Wang

    Titanium dioxide nanoparticles (TiO2 NPs) can induce the cell cycle arrest in spermatogonia, and the JAK2/STAT3 signaling pathway plays a pivotal role in cell cycle progression, but the specific upstream regulatory mechanisms are not completely clarified. The purpose of this study was to investigate whether CXCL13 regulated the JAK2/STAT3 signaling pathway to participate in cell cycle arrest after mouse spermatogonia cell line (GC‐1) exposure to TiO2 NPs. The GC‐1 cells were treated with TiO2 NPs at different concentrations (0, 10, 20, 30, and 40 μg/mL) for 24 h to detect cell viability, cell cycle distribution, CXCL13 protein, JAK2/STAT3 pathway‐related proteins, and cell cycle–related proteins. The CXCL13 recombinant protein was used to verify the role of CXCL13 in cell cycle and JAK2/STAT3 signaling pathway. TiO2 NPs inhibited cell viability; regulated cell cycle–related proteins including remarkably decreased Cyclin D1, CDK4, Cyclin E1, and CDK2 as well as increased p21; and induced cell cycle arrest at the G0/G1 phase. TiO2 NPs inhibited the levels of CXCL13 protein and weakened the activation of the JAK2/STAT3 signaling pathway by reducing the levels of p‐JAK2/JAK2 and p‐STAT3/STAT3 proteins. Furthermore, CXCL13 mitigated the suppression of the JAK2/STAT3 signaling pathway and the G0/G1 cell cycle arrest caused by TiO2 NPs. Taken together, TiO2 NPs downregulated the expression of CXCL13 to inhibit the activation of downstream JAK2/STAT3 signaling pathway, eventually inducing cell cycle arrest at the G0/G1 phase. These results provide a novel insight for complemented understanding of the mechanisms of TiO2 NPs–induced cell cycle arrest in GC‐1 cells.


  • The Role of PI3K/AKT/HIF‐1α Pathway in the Effect of Nano‐TiO2 on Lactate Production in TM4 Cells

    by Hongmei Chang, Siqi Zhao, Yuzhu Lei, Yunhua Hu, Yizhong Yan, Guanling Song

    Titanium dioxide nanoparticles (nano‐TiO2) can cause a reduction in sperm counts, and lactate production in Sertoli cells plays a key role in spermatogenesis. The aim of this study was to evaluate the effect of nano‐TiO2 on lactate production in mouse Sertoli cell line (TM4 cells) and to investigate whether the effect is mediated through the PI3K/AKT/HIF‐1α pathway. After TM4 cells were treated with different concentrations of nano‐TiO2 for 48 h, cell viability, contents of glucose and lactate, and the expression levels of GLUT3 and key enzymes (HK1, HK2, PFKM, ENO1, LDH) during lactate production were detected. PI3K/AKT/HIF‐1α pathway proteins were measured. In addition, PI3K agonist (IGF‐1) was added to explore whether nano‐TiO2 regulates HIF‐1α through PI3K/AKT pathway, thereby affecting the production of lactate in TM4 cells. The results showed that nano‐TiO2 significantly inhibited TM4 cell viability, increased glucose content, decreased lactate content, and downregulated the expression levels of GLUT3 and key enzymes during lactate production. Meanwhile, nano‐TiO2 decreased the expression of PI3K/AKT pathway phosphorylated proteins and HIF‐1α, and IGF attenuated this effect of nano‐TiO2. Collectively, nano‐TiO2 downregulated the expression level of proteins and enzymes related to lactate production in TM4 cells by inhibiting PI3K/AKT/HIF‐1α pathway, resulting in the decrease of lactate production in TM4 cells.


  • The ROS Mediates MCUb in Mitochondria-Regulated Apoptosis of TM4 Cells Induced by Titanium Dioxide Nanoparticles

    by Chenhao Sun, Qianqian Wang, Pengfei Li, Ruoyun Dong, Yuzhu Lei, Yunhua Hu, Yizhong Yan, Guanling Song

    Titanium dioxide nanoparticles (TiO2 NPs) can cause mitochondrial apoptosis of TM4 cells associated with reactive oxygen species (ROS) accumulation and Ca2+ overload, but the relations among these processes remain unclear. This study aimed to evaluate whether the accumulation of ROS caused by TiO2 NPs inhibits MCUb expression, leading to mitochondrial calcium overload and subsequent cell apoptosis through the mitochondrial pathway. TM4 cells were exposed to different concentrations of TiO2 NPs (0, 25, 50, 75, 100 μg/mL) for 24 h. We assessed cell viability, ROS level, MCUb and VDAC1 expression, mitochondrial and cytoplasmic Ca2+ levels, mitochondrial membrane potential (MMP), apoptosis rate, and key proteins related to mitochondrial apoptosis (Bcl-2, Bax, Caspase 3, Caspase 9, p53 and Cyt c). Additionally, the effect of N-acetylcysteine (NAC) on MCUb expression, calcium homeostasis, and cell apoptosis was evaluated. Compared to control group, TiO2 NPs significantly increased ROS level, downregulated MCUb expression, elevated Ca2+ levels in mitochondria and cytoplasm, and enhanced mitochondria-regulated apoptosis, starting from the 50 μg/mL TiO2 NPs group. However, NAC significantly increased MCUb expression, attenuated Ca2+ levels in mitochondria and cytoplasm, and reduced mitochondria-related apoptosis. In conclusion, TiO2 NPs induced ROS accumulation, which inhibited the expression of MCUb. The decreased MCUb level led to Ca2+ overload in mitochondria, causing TM4 cell apoptosis via the mitochondrial pathway. This research elucidates, for the first time, the role of MCUb and its relation with ROS in apoptosis of TM4 cells induced by TiO2 NPs, which supplementing the molecular mechanism of cell apoptosis caused by TiO2 NPs. Graphical Abstract